Old Web
English
Sign In
Acemap
>
Paper
>
A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL in Adults
A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for BCR-ABL1-Positive ALL in Adults
2021
Marlise R. Luskin
Kristen E. Stevenson
Lourdes M. Mendez
Eunice S. Wang
Martha Wadleigh
Jacqueline S. Garcia
Richard Stone
Hyun Hwan An
Ella Hagopian
Ilene Galinsky
Lindsey Rae
Rebecca Leonard
Daniel J. DeAngelo
Mark A. Murakami
Keywords:
Oncology
Dasatinib
phase i study
Internal medicine
bcr abl1
Prednisone
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]